ArticleResearch in pharmaceutical sciences2023

Computational design of newly engineered DARPins as HER2 receptor inhibitors for breast cancer treatment.

Maryam Beheshti Isfahani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.